The Role of the Advanced Practitioner in Maintaining Adherence in Patients on Oral Oncolytics




Posted: 12/8/2017
Expires: 12/7/2018
Credits/Contact Hours: 1.0

This activity is supported by unrestricted educational grants from AstraZeneca; Bayer HealthCare Pharmaceuticals Inc.; Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Novartis Pharmaceutical Corporation; and Taiho Oncology, Inc.

This CME/CE/CPE accredited activity is jointly provided by



         




Instructions for Earning CE credit

If you would like to earn credit, you must take the pre-test first by clicking here

Review CE information and Begin Pre-test


Please visit the Oral Oncolytics Adherence Knowledge Center at: http://www.advancedpractitioner.com/ce/2017/oral-oncolytics.aspx

rowCount++; var rowCount = 0; rowCount++;
 

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.